GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Postow discusses first line therapy for BRAF positive metastatic melanoma.

A huge thank you to Merck for sponsoring this program.

GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Postow discusses understanding immunotherapy resistance mechanisms in melanoma.

GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Postow discusses future prospects for immunotherapy agents in advanced melanoma.

GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. McKean discusses if there is a role for molecular testing in early melanoma management.

GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. McKean discusses the current status of sentinel lymph node mapping and completion lymphadenectomy.

GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chiefof Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Agarwala discusses adjuvant therapy for melanoma.

A huge thank you to our sponsor, Merck!

GRACE is excited to bring you a new series on current updates in Melanoma Treatment

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.   

In this video, Dr. McKean discusses combination immunotherapy vs. monotherapy for Metastatic Melanoma.